These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4054832)

  • 1. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and prolactin variants in normal subjects. Relative proportions in morning and afternoon samples.
    Warner MD; Sinha YN; Peabody CA
    Horm Metab Res; 1993 Aug; 25(8):425-9. PubMed ID: 8225187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.
    Maddox PR; Jones DL; Mansel RE
    Br J Cancer; 1992 Mar; 65(3):456-60. PubMed ID: 1558804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid-stimulating hormone and prolactin levels in breast cancer.
    Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
    Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations and peritoneal loss of growth hormone and growth-hormone-binding protein activity in older adults undergoing continuous ambulatory peritoneal dialysis: comparison with haemodialysis patients and normal subjects.
    Kagan A; Zadik Z; Gertler A; Ulman M; Bar-Khayim Y
    Nephrol Dial Transplant; 1993; 8(4):352-6. PubMed ID: 8390011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between prolactin and somatotropic hormone in human breast cancer].
    Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
    Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rovensky J; Imrich R; Malis F; Zlnay M; Macho L; Koska J; Vigas M
    J Rheumatol; 2004 Dec; 31(12):2418-21. PubMed ID: 15570644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.
    Pannuti F; Martoni A; Farabegoli G; Piana E
    Chemioterapia; 1985 Apr; 4(2):127-34. PubMed ID: 3159487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet, serum, breast fluid growth hormone, and prolactin levels in normal premenopausal Finnish and American women.
    Rose DP; Boyar AP; Kettunen K
    Nutr Cancer; 1988; 11(3):179-87. PubMed ID: 2841652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone.
    Ataya KM; Subramanian MG; Lawson DM; Gala RR
    J Reprod Med; 1996 Mar; 41(3):156-60. PubMed ID: 8778412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between PRL levels and steroid receptors in breast cancer.
    Marugo M; Fazzuoli L; Bernasconi D; Berta S; Giordano G
    Anticancer Res; 1988; 8(4):819-23. PubMed ID: 3178171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone concentrations in postmenopausal patients with breast cancer.
    Jones MK; Ramsay ID; Booth M; Collins WP
    Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.